Interstitial Keratitis Secondary to Severe Hidradenitis Suppurativa Responding to Adalimumab Reply

被引：0
|
作者：
Demirci, Hakan [1 ]
Fernandez, Anna G. Alzaga [2 ]
Darnley-Fisch, Deborah A. [2 ]
Steen, Daniel W. [2 ]
机构：
[1] Univ Michigan, WK Kellogg Eye Ctr, Ann Arbor, MI 48109 USA
[2] Henry Ford Hosp, Dept Ophthalmol, Detriot, MI USA
来源：
CORNEA | 2012年 / 31卷 / 02期
关键词：
D O I：
10.1097/ICO.0b013e31821213a7
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：206 / 206
页数：1
相关论文
共 50 条
  • [41] Successful Treatment of Recalcitrant Hidradenitis Suppurativa with Adalimumab
    Gorovoy, Ian
    Berghoff, Adar
    Ferris, Laura
    CASE REPORTS IN DERMATOLOGY, 2009, 1 (01): : 71 - 77
  • [42] Candida Esophagitis Associated With Adalimumab for Hidradenitis Suppurativa
    Nazarian, Roya S.
    Farberg, Aaron S.
    Smith, Barry L.
    CUTIS, 2021, 107 (03): : E6 - E7
  • [43] Facial hidradenitis suppurativa successfully treated with adalimumab
    Cembrero Saralegui, Hirune
    Alfageme Roldan, Fernando
    Grau Perez, Merce
    Turrion Merino, Lucia
    Elosua Gonzalez, Marta
    Lopez-Negrete Arenal, Elena
    Cabeza Martinez, Rita
    Siguenza Sanz, Mercedes
    Roustan Gullon, Gaston
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 90 - 91
  • [44] Successful desensitization with adalimumab in a patient with hidradenitis suppurativa
    Foncubierta Fernandez, A.
    Gutierrez Fernandez, D.
    Cruz Carmona, M. J.
    Moreno Ancillo, A.
    Anguita Carazo, J. L.
    Fernandez Anguita, M. J.
    ALLERGY, 2015, 70 : 552 - 552
  • [45] Reply to "Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa"
    Martora, Fabrizio
    Potestio, Luca
    Battista, Teresa
    Megna, Matteo
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (08) : e735 - e736
  • [46] Population Pharmacokinetics and Immunogenicity of Adalimumab in Adult Patients with Moderate-to-Severe Hidradenitis Suppurativa
    Ahmed Nader
    Denise Beck
    Peter Noertersheuser
    David Williams
    Nael Mostafa
    Clinical Pharmacokinetics, 2017, 56 : 1091 - 1102
  • [47] Population Pharmacokinetics and Immunogenicity of Adalimumab in Adult Patients with Moderate-to-Severe Hidradenitis Suppurativa
    Nader, Ahmed
    Beck, Denise
    Noertersheuser, Peter
    Williams, David
    Mostafa, Nael
    CLINICAL PHARMACOKINETICS, 2017, 56 (09) : 1091 - 1102
  • [48] Cellulitis-like Sweet Syndrome caused by adalimumab therapy for severe hidradenitis suppurativa
    Canal Garcia, Elena
    Vargas Ramos, Johanna del Pilar
    Aguayo Ortiz, Rafael
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2020, 61 (04) : E448 - E449
  • [49] Adalimumab long-term survival in patients with moderate-to-severe hidradenitis suppurativa
    Vilarrasa, Eva
    Lopez-Llunell, Cristina
    Agut-Busquet, Eugenia
    Bittencourt, Flavia
    Puig, Luis
    Romani De Gabriel, Jorge
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 90 - 90
  • [50] Long-term safety of adalimumab for patients with moderate-to-severe hidradenitis suppurativa
    Tzanetakou, Vassiliki
    Stergianou, Dimitra
    Giamarellos-Bourboulis, Evangelos J.
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (04) : 381 - 393
12345